Yajing Chen - 07 Jul 2023 Form 3 Insider Report for Zai Lab Ltd (ZLAB)

Role
Chief Financial Officer
Signature
By: /s/ Bruce Blefeld, Attorney-in-Fact
Issuer symbol
ZLAB
Transactions as of
07 Jul 2023
Transactions value $
$0
Form type
3
Filing time
17 Jul 2023, 16:05:31 UTC
Next filing
21 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ZLAB American Depositary Shares 46K 07 Jul 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ZLAB Stock Option (Right to Buy) 07 Jul 2023 American Depositary Shares 8K $102.75 Direct F1, F2
holding ZLAB Stock Option (Right to Buy) 07 Jul 2023 American Depositary Shares 5K $104.42 Direct F1, F3
holding ZLAB Stock Option (Right to Buy) 07 Jul 2023 American Depositary Shares 20K $45.47 Direct F1, F4
holding ZLAB Stock Option (Right to Buy) 07 Jul 2023 American Depositary Shares 26K $33.95 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Stock Option is exercisable for one American Depositary Share, which represents ten Ordinary Shares of the issuer.
F2 The option vests in equal annual installments over five years beginning on 10/01/2022, the first anniversary of the date of grant.
F3 The option vests in equal annual installments over four years beginning on 11/01/2022, the first anniversary of the date of grant.
F4 The option vests in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant.
F5 The option vests in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney